Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Sales | 79,204 | 86,160 | 97,074 | 122,473 | 205,197 |
| Gross Profit | 79,204 | 86,160 | 97,074 | 122,473 | 205,197 |
| Operating Expenses | 216,411 | 210,004 | 206,647 | 164,112 | 168,459 |
| Operating Income | -137,207 | -123,844 | -109,573 | -41,639 | 36,738 |
| Interest Expense | 5,148 | 0 | 0 | 0 | 0 |
| Other Income | 11,360 | 1,656 | 1,994 | 6,620 | 8,819 |
| Pre-tax Income | -130,995 | -122,188 | -107,579 | -35,019 | 45,557 |
| Income Tax | 2,821 | -433 | -28,583 | 1,149 | -826 |
| Net Income Continuous | -133,816 | -121,755 | -78,996 | -36,168 | 46,383 |
| Net Income | $-133,816 | $-121,755 | $-78,996 | $-36,168 | $46,383 |
| EPS Basic Total Ops | -6.38 | -5.91 | -3.92 | -1.81 | 2.37 |
| EPS Basic Continuous Ops | -6.38 | -5.91 | -3.92 | -1.81 | 2.37 |
| EPS Diluted Total Ops | -6.38 | -5.91 | -3.92 | -1.81 | 2.21 |
| EPS Diluted Continuous Ops | -6.38 | -5.91 | -3.92 | -1.81 | 2.21 |
| EPS Diluted Before Non-Recurring Items | -6.38 | -5.91 | -3.92 | -0.89 | 2.21 |
| EBITDA(a) | $-137,692 | $-119,700 | $-104,123 | $-37,691 | $35,660 |